‘Smart’ pillbox won’t let seniors or their caregivers forget their daily doses, company promises
By
Aaron Dorman
Dec 12, 2023
A new “smart” pillbox system can help older adults, their families and their caregivers coordinate to maintain proper medication regimens.
Over-the-counter meds, exercise most prevalent treatment for chronic pain
Nov 20, 2023
The likelihood of using prescription opioids was higher for older persons, those with public insurance, and those with more severe pain, after adjustment for multiple factors.
ACC: Semaglutide beneficial in obesity-related heart failure, type 2 diabetes
Apr 09, 2024
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.
Outpatient metformin treatment reduces incidence of long COVID
Jun 12, 2023
The beneficial effect of metformin was consistent across subgroups.
Virtual community of long-term care and other providers commits to ‘age-friendly’ care guidelines
By
Aaron Dorman
Nov 03, 2023
Recruiting has begun for providers for the fifth iteration of an ‘age friendly’ network who will have access to webinars, coaching and more.
10 percent of new drugs approved without meeting primary efficacy end points
Feb 14, 2023
The findings were seen for 21 drug approvals between 2018 and 2021, with only one-third needing postmarketing studies.
Experts strongly object to proposed telemedicine restrictions at DEA hearing
By
Aaron Dorman
Sep 15, 2023
Access to telemedicine is not just beneficial but also vital in many parts of the US, doctors and other healthcare leaders argued this week before the DEA.
Solriamfetol effective for managing ADHD in adults
Oct 17, 2023
Solriamfetol was found to be well-tolerated with no significant effect on mean heart rate or systolic or diastolic blood pressure.
Medication managed by AI can help patients feel better, study shows
By
Aaron Dorman
Aug 02, 2023
New research on an AI-tool for medication management showed cost savings and effective decision-making for high-risk patients.
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.